drugset / Trial / NCT00755482

Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee

NCT00755482 ↗

Phase 1/2 Completed 29 enrolled Marigot Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this trial is to evaluate the effect of Aquamin F versus placebo on NSAID (non-steroidal anti-inflammatory drug) dose reduction in subjects with osteoarthritis of the knee. Hypothesis 1: After 12 weeks of treatment, subjects taking Aquamin F will use significantly less NSAID medications for symptoms of osteoarthritis versus placebo alone. Hypothesis 2: No significant differences will be seen for adverse events between the subjects taking Aquamin F or placebo.

Timeline

Start
2006-01
Primary completion
—
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aquamin F Other / unclassified 2400 mg —

Indications